HO 0306

Drug Profile

HO 0306

Alternative Names: HO/03/06; HO0306

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator HealOr
  • Class Anti-infectives; Anti-inflammatories
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Wound infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Wound-infections in Israel (Topical)
  • 14 Jul 2011 Phase-I clinical trials in Wound infections in Israel (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top